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Abstract
Genetic analysis of factors affecting risk to develop excessive ethanol drinking has been extensively studied in humans and
animal models for over 20 years. However, little progress has been made in determining molecular mechanisms underlying
environmental or non-genetic events contributing to variation in ethanol drinking. Here, we identify persistent and
substantial variation in ethanol drinking behavior within an inbred mouse strain and utilize this model to identify gene
networks influencing such ‘‘non-genetic’’ variation in ethanol intake. C57BL/6NCrl mice showed persistent inter-individual
variation of ethanol intake in a two-bottle choice paradigm over a three-week period, ranging from less than 1 g/kg to over
14 g/kg ethanol in an 18 h interval. Differences in sweet or bitter taste susceptibility or litter effects did not appreciably
correlate with ethanol intake variation. Whole genome microarray expression analysis in nucleus accumbens, prefrontal
cortex and ventral midbrain region of individual animals identified gene expression patterns correlated with ethanol intake.
Results included several gene networks previously implicated in ethanol behaviors, such as glutamate signaling, BDNF and
genes involved in synaptic vesicle function. Additionally, genes functioning in epigenetic chromatin or DNA modifications
such as acetylation and/or methylation also had expression patterns correlated with ethanol intake. In verification for the
significance of the expression findings, we found that a histone deacetylase inhibitor, trichostatin A, caused an increase in 2-
bottle ethanol intake. Our results thus implicate specific brain regional gene networks, including chromatin modification
factors, as potentially important mechanisms underlying individual variation in ethanol intake.
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Introduction
Over 121 million Americans drink alcohol, while less than 10%
of the population drinks excessively [1,2]. In 2000, alcohol
consumption and alcoholism were responsible for 3.5% of all
deaths in the United States and cost over $185 billion annually [3].
These facts highlight the importance of identifying those factors
that may influence the variability in drinking behaviors. Extensive
studies in humans have suggested that genetic factors account for
about 40–60% of the risk for alcoholism [4,5,6,7]. Work in
humans and animal models over the last 20 years has documented
genetic intervals [8,9,10] or individual genes [11,12] contributing
to variation in behavioral responses to ethanol.
Despite such progress on identifying genetic influences in
alcoholism, little progress at the molecular level has revealed
mechanisms that mediate environmental influences on ethanol
behaviors or alcoholism. It is well documented that environmental
influences such as stress or exposure to conditional stimuli can
modify ethanol drinking or cause recidivism in abstinent
alcoholics. Understanding the molecular mechanisms underlying
such environmental influences on ethanol behaviors would
augment the genetic progress mentioned above.
C57BL/6 (B6) inbred mice have been widely used as a model
for studying alcohol abuse related behaviors and the genetic basis
of alcohol abuse since these mice voluntarily consume large
volumes of unadulterated ethanol [10,13,14,15]. However, a
number of prior studies have documented remarkable degrees of
stable, individual variation in 2-bottle choice drinking behavior in
rodents including several studies that have shown individual
variation can occur within a single inbred strain including C57
substrains C57BL/6J [16] and C57BL/10 [17,18]. This eliminates
factors such as genetic differences in taste or ethanol reward as
causal for the variation in drinking behavior. Studies in C57BL/6J
mice suggest that non-genetic persistent individual differences in
drinking behavior are the major source of variance in ethanol
drinking in these animals, outweighing substantial environmental
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factors are strictly controlled, offers considerable power for
studying molecular mechanisms of environmental modulation of
ethanol drinking behavior.
Here, we demonstrate a remarkable degree of individual
variation in ethanol drinking behavior across individual mice
from the C57BL/6NCrl inbred line. We have performed whole
genome expression profiling in individual mice to finely dissect
molecular factors underlying this individual variation in ethanol
drinking behavior. We hypothesized that an as yet unidentified
non-genetic factor has caused long-lasting brain signaling
alterations that influence ethanol preference and intake in these
mice. By characterizing gene networks differentially expressed
between ethanol preferring and avoiding mice, we have identified
putative epigenetic mechanisms such as alterations in chromatin
acetylation that may regulate gene transcription and influence
drinking patterns. We expect that these studies may contribute to
the identification of novel targets for pharmacotherapy in
alcoholism.
Methods
Ethics Statement
All procedures were approved by Virginia Commonwealth
University Institutional Animal Care and Use Committee under
protocol numbers AM10332 and AM10139, and followed the
NIH Guide for the Care and Use of Laboratory Animals (NIH
Publications No. 80–23, 1996).
Animals
Male C57BL/6NCrl mice (age 42–49 days) from Charles River
Laboratories (Wilmington, MA) were habituated to the vivarium
(5 mice/cage) for 1 week followed by individual housing for 1
week prior to beginning drinking experiments. Cages and bedding
(Harlan Sani-chips, #7090A, Harlan, Teklad, Madison, WI) were
changed weekly. Mice were housed in a temperature and light
controlled room (12:12 h cycle, lights on at 0600) with free access
to standard chow (Harlan Teklad #7912, Madison, WI) and
water.
Two-bottle choice drinking
Experiment 1: Voluntary two-bottle choice drinking was
performed as described previously [19]. Two bottles containing
10%(w/v) ethanol (Aaper Alcohol and Chemical Co. Shelbyville,
KY) or tap water were placed into the home cage at the beginning
of the dark cycle. Tube position was varied every two days (L, L,
R, R). Drinking sessions lasted 18 hours/day followed by 6 hours
access to water only. Mice had four consecutive drinking sessions
followed by four days of abstinence repeated four times to give 16
total drinking sessions. Tissues from prefrontal cortex (PFC),
nucleus accumbens (NAc) and the ventral midbrain region (VMB;
including the ventral tegmental area) were harvested 6 days after
the last drinking session for microarray analysis as previously
described [20]. Tissue was stored at 280uC until RNA isolation.
Experiment 2 was conducted in an identical manner (n-21 mice)
except tissue was harvested for Western blotting as described
below.
Experiment 3: For studies on ethanol preference in littermates,
two cohorts of male B6 littermates were purchased as littermates
from Charles River. Breeding at Charles River facility used two
females paired to one male. Offspring were weaned at day 21,
shipped to our vivarium at day 35 and remained housed as
littermates until the beginning of the study. 10 litters were
represented with 3–5 males per litter (n=36 total). Mice were
individually housed for 7 days then presented with 10%(w/v)
ethanol for 18 h/day in a two-bottle choice paradigm for 14 days.
Taste Discrimination
Experiment 4: Taste preference for a bitter or sweet solution
was measured using quinine or saccharin vs. water in a two-bottle
choice paradigm. Mice (n=16) were tested for ethanol preference
for 14 days as in experiment 1 but without deprivation periods,
and then allowed to rest for 7 days with only water and food
available. Half the mice were given two bottles containing either a
0.1 mM quinine solution or tap water and the others given a
choice between 0.033% saccharin/water. Bottles were alternated
every other day. Consumption of quinine/water or saccharin/
water was measured daily for 3 days (18 h/day) after which the
other tastant was offered for 3 days in a counterbalanced design.
HDAC Inhibitor Studies
Experiment 5: 18 male C57BL/6NCrl mice, acclimated to a
reverse-light cycle, were used to test effects of trichostatin A (TSA,
a class I and II HDAC inhibitor) on ethanol drinking. Voluntary
ethanol drinking was initiated as before except these mice had
access 24 hours/day, changed at 1200 h. Following 7 days
baseline ethanol access, mice were divided into two groups
balanced for baseline intake. Mice in the TSA group (n=9) were
injected with 2 mg/kg TSA i.p. (dissolved in 1:5 DMSO:saline) for
5 days. Control mice (n=9) were injected with vehicle. Mice had
continuous ethanol access during the entire study (39 days total).
Experiment 6: Western blotting for acetyl-Histone-H4 was used
to verify CNS activity of i.p. TSA. C57BL/6NCrl mice (n=12)
received a single i.p. injection of 2 mg/kg TSA or vehicle. After
24 hours, nucleus accumbens was dissected for Western blotting as
described below.
The effect of TSA on ethanol metabolism was assayed in a
separate group of mice (Experiment 7). Male C57BL/6NCrl mice
(n=425/group; 37 mice total) received 2 mg/kg TSA or vehicle
for 5 consecutive days. On day 6, all mice were injected with
2 mg/kg ethanol. Trunk blood was harvested from mice at 10, 60,
120 and 180 minutes following ethanol administration. Whole
blood samples (20 ml) were placed into 20-ml headspace vials with
960 ml water and 20 ml 1-propanol internal standard. Samples
were tested for ethanol concentration using a Hewlett Packard
5890A gas chromatograph equipped with a flame ionization
detector, 2 meter 5% Carbowax 20M 80/120 mesh packed
column (Restek, Bellefonte, PA) and CTC Combi-Pal headspace
autosampler. Data were acquired by Clarity software (Apex data
systems, Prague, CZ) and analyzed by linear regression with no
weighting. A 7-point calibration curve preceded the analysis and
quality control ethanol standards were interspersed with each set
of samples. Up to 3 replicates were analyzed from each animal and
averaged if sufficient blood was collected.
RNA isolation and microarray hybridization
Total RNA was extracted from PFC, NAc and VMB from
individual mice in STAT 60 reagent (Tel-Test, Friendswood, TX)
according to the manufacturer’s protocol. RNA concentration and
quality was assessed by Experion automated electrophoresis
(BioRad, Hercules, CA). Total RNA (2 mg) was transcribed into
double-stranded cDNA using the One-cycle Targeting and
Control Reagent kit (Affymetrix, Santa Clara, CA). Biotin-labeled
cRNA was synthesized from cDNA, purified and fragmented
according to manufacturer’s instructions.
Labeled cRNA from individual animals (n=19) was hybridized
to a single microarray for each brain region (n=57 total
microarrays). Samples were analyzed on oligonucleotide arrays
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characterized genes and expressed sequence tags. Array hybrid-
ization and scanning were performed exactly according to
manufacturer’s protocols (Affymetrix).
Microarray data analysis
Microarray data were processed using GeneChip Operating
Software v4.1 (GCOS, Affymetrix) and normalized to a mean total
hybridization intensity of 190. All raw microarray data is deposited
at the Gene Expression Omnibus repository (GEO) under accession
number GSE26506. All microarray data is MIAME compliant.
Array quality was assessed by accepting arrays with scaling factor
,3, 39–59-actin ratio ,2, and by examining linearity and inter-chip
correlations of intensity values. Arrays determined to be acceptable
(57/58) were further analyzed using the Robust Multichip Average
(RMA) low-level analysis algorithm to summarize probeset
expression data [21]. Probesets with RMA expression values ,4.5
consistently across all microarrays were filtered to reduce variance
from low expressing genes. To identify gene expression correlated
with ethanol drinking behavior across individual mice, RMA values
for each brain region were correlated [22] to a drinking scale
calculatedfromeachmouse’sethanolintakeaveragedoverthelast8
drinking days using the template matching tool in T-Mev (TIGR
Multiple expression viewer [23]). P-values from the template
matching analysis were then used in estimating the false discovery
rate (FDR) using the q value method [24] in the R programming
environment [25]. Probesets were considered significant using a
FDR of 1%. Significant probesets were further studied for
functional gene sets by hierarchical clustering (T-MeV, average
linkage) and bioinformatics analyses as below.
The Expression Analysis Systematic Explorer (EASE version
1.21) [26] nonbiased annotation analysis tool was used to identify
biological themes among gene expression profiles and to group
genes into functional classifications. EASE results were filtered to
remove categories with more than 250 members and EASE scores
of .0.05. Redundant categories with the same gene members
were removed to yield a single representative category. Additional
bioinformatics analysis of gene lists were performed with Ingenuity
Pathway Analysis (IngenuityH Systems, www.ingenuity.com) and
Bibliosphere (http://www.genomatix.de). These tools utilize
biomedical literature associations to annotate genes with biological
functions and cellular components. IPA also generates networks of
interrelated genes based on their curated knowledge base.
Principal Component Analysis
As an alternative to correlating gene expression to the average
of the last 8 days of ethanol drinking data, we conducted a
principal components analysis to reduce the number of covariates
and identify the few principal components that account for a
sufficient proportion of the variability and contain almost as much
information as the full data set. The first 2 principal components
accounted for 0.77 of the total variance. For each brain region,
probeset-specific linear models predicting expression as a function
of the two independent principal components were fit. An overall
F-test was used for calculating P-values for each probe set level
linear model. Genes significant at p,0.05 level were selected for
further bioinformatics analysis and comparison with results from
using average ethanol intake over the last eight days.
Association with alcohol-preferring and non-preferring
mouse models
Genes significantly correlated to ethanol drinking patterns in the
present study, using a false discovery rate of 1%, were analyzed for
overlap with previously published gene sets having expression
significantly different between alcohol-preferring or non-preferring
mouse models based on the criteria |d|$0.5 and q,0.05 [27].
Genes intersecting between these data sets and the studies
performed here were further analyzed using bioinformatics tools
as previously described.
Western blot analysis
Twenty-one C57BL/6NCrl mice (Exp. 2) voluntarily consumed
ethanol as described above and brains were harvested six days
following the last drinking session. Nucleus accumbens was
homogenized in NP40 buffer with protease inhibitors (Roche,
Indianapolis, IN). Western blotting was performed as described
[20]. RAB3A blots were probed with rabbit anti-RAB3A
(Millipore, Bedford, MA) and mouse anti-beta-actin (AbCam,
Cambridge, MA) and visualized with HRP (GE Healthcare,
Buckinghamshire, UK) and ECL reagent (Amersham Biosciences,
Piscataway, NJ). Acetyl-Histone H4 blots were probed with rabbit
anti-acH4 (AbCam, Cambridge, MA) and mouse anti-GAPDH
(Millipore, Bedford, MA). Images were digitized and protein
expression was determined as area under the curve normalized to
beta-actin using ImageJ (NIH, Bethesda, MD).
Results
Individual Variation in Ethanol Drinking Behaviors
C57BL/6 (B6) male mice from Charles River Laboratories
consumed a substantial amount of ethanol, 6.4760.99 g/kg/18 h,
in the voluntary two-bottle choice (10% w/v ethanol or water) self-
administration paradigm. Interestingly, mice showed a large degree
of inter-individual variation in ethanol drinking (Figure 1a), ranging
from 0.2860.14 g/kg/18 h to 14.3960.47 g/kg/18 h. This cor-
responds to almost complete ethanol abstinence (ethanol prefer-
ence, 0.01560.0074) to very high ethanol preference (0.9560.035).
Ethanol preference was significantly correlated to ethanol intake
(R=0.949,p,0.001 Pearson Correlation)sincethere were minimal
differencesin total fluid consumed (Figure 1b). The onlymouse with
significantly higher fluid consumption had the lowest ethanol intake
and preference. The variation in ethanol intake across individual
mice was very consistent over the course of the drinking sessions
(Figure 1c). Ethanol intake for the first 4 days of drinking was highly
correlated with intake over the last 4 days of drinking (R=0.676,
p=0.0011, day1–4 vs. day 25–28, see Table 1). This stability
suggested that most of the observed variance was due to between-
subject individual differences rather than random environmental
factors.
To assess whether taste discrimination was contributing to
variation in ethanol drinking, we performed an additional
experiment (Exp. 4) where mice (n=16) were assessed for ethanol
drinking, followed by studies on preference for quinine (0.1 mM)
or saccharin (0.033%). While there was some individual variation
in quinine consumption, preference for saccharin (R=0.142,
p=0.589) or quinine (R=0.196, p=0.468) showed no significant
correlation to ethanol preference (data not shown). These results
argue against sweet or bitter taste as a major contributing factor
for the observed individual differences in ethanol preference.
Additionally, we determined whether the observed individual
variation in ethanol drinking was due to robust differences
between litters (Exp. 3). In two separate cohorts consisting of 10
litters (n=3–5 males/litter, 36 total), ethanol intake over 14 days
of baseline drinking did not differ between litters (F(9,32)=1.258
p=0.2967, Table S1). Ethanol preference also did not differ
between litters (F(9,32)= 1.629, p=0.1489, Table S1). The
average ethanol intake in the littermate study (6.9660.53 g/kg/
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the non-littermate studies (Fig. 1). Additionally, the range of
drinkers (0.8 – 10.8 g/kg/18 h) was very similar to that shown in
Fig. 1 and was evenly distributed between the litters, suggesting
that simple litter effect differences do not greatly contribute to the
inter-individual variability of intake in these mice. While these
observations argue against litter effects playing a major contribu-
tion to the individual variability in ethanol drinking, one cannot
fully exclude the possibility that other factors, such as sex
composition of the litter may alter hormonal exposure levels
during the time when hormones organize the brain and affect an
animal’s drug response. A much larger study design would be
needed to tease out such minor contributions.
Differential gene expression in ethanol preferring and
avoiding mice
We hypothesized that persistent individual variation in ethanol
drinking behaviors within an inbred strain might be caused by
differential basal gene expression patterns generated by unknown
environmental influences. Further, such differential gene expres-
sion patterns could be used to identify molecular pathways
contributing to individual variation in ethanol drinking. We
profiled 3 brain regions in individual mice: nucleus accumbens
(NAc), prefrontal cortex (PFC) and ventral midbrain region
(VMB). These brain regions were chosen because they are major
components of the mesocorticolimbic dopamine reward pathway
activated by ethanol and other drugs of abuse [28]. Pair-wise
comparisons of microarrays showed gene intensities of individual
arrays were highly correlated with the lowest Pearson correlation
value being 0.97 (not shown). Each array passed rigorous quality
control checks in our laboratory showing that micro-dissected
brain regions from individual animals could be reliably analyzed
by microarrays without requiring sequential rounds of probe
amplification.
To identify molecular factors related to ethanol drinking
behaviors, gene expression patterns were first correlated to a
drinking template created from the last 8 days of ethanol access
following a third round of ethanol deprivation (see Methods). This
design was chosen because the mice did not show an ethanol
deprivation effect after this time point (Figure S1 and [19]). As we
have reported previously, mice showed a diminishing deprivation
effect after the first and second abstinence periods that
disappeared with the third abstinence. Utilizing multiple rounds
of ethanol deprivation enabled assessment of the stable individual
ethanol intake while providing a window where tissue could be
harvested with animals off ethanol. Correlations of ethanol intake
and gene expression were performed separately for each brain
region, using a false discovery rate of 1% (see Table S2 for gene
lists). The number of genes significantly correlated to ethanol
drinking was similar in NAc and PFC with fewer transcripts
regulated in the VMB (Figure S2). Not surprisingly, there was little
overlap in the identity of significant genes across brain regions
(Figure S2). Therefore, gene expression data from each brain
region was further analyzed separately.
To identify gene expression correlated with drinking behavior,
we also performed a principal component analysis on the daily
drinking activity data to reduce the number of covariates, rather
than averaging the drinking data over an interval. The first two
principal components (PC) accounted for 77% of the total
variance. For each brain region, probe set-specific linear models
predicting expression as a function of the two independent
principal components were fit. The number of transcripts which fit
the linear model at a level p,0.05 was 547 in NAc, 670 in PFC
and 725 in VMB (Table S3). When these data were intersected
with the results from analysis of averaged drinking intake, a highly
significant degree of overlap was found between the two results. Of
the number of transcript correlating with averaged drinking
Figure 1. Ethanol drinking in individual C57BL/6NCrl mice. A.
Ethanol intake expressed in grams per kilogram body weight over
18 hours of ethanol access. Mice show a robust, but persistent variation
in ethanol drinking. B. Total liquid consumed (ml ethanol + ml water) in
18 h/day. C. Scattergram of ethanol drinking on days 1–4 versus days
17–28, correlation R=0.738, p,0.0002.
doi:10.1371/journal.pone.0021100.g001
Table 1. Correlation of initial ethanol intake versus
subsequent rounds of drinking following deprivation.
d1-4
intake
d9-12
intake
d17-20
intake
d25-28
intake
d1-4 intake 1.000 0.703 0.772 0.676
d9-12 intake 0.703 1.000 0.850 0.779
d17-20 intake 0.772 0.850 1.000 0.993
d25-28 intake 0.676 0.779 0.993 1.000
doi:10.1371/journal.pone.0021100.t001
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genes in NAc, 223 in PFC (26%) and 154 in VMB (27%).
Bioinformatics Analysis of Regional Microarray Data
Gene lists from microarray analyses were analyzed for over-
representation of biological functions or gene network relation-
ships using several different tools as described in Methods. As
mentioned below, there was a striking similarity between gene lists
resulting from analysis of either average drinking data or the PC
data, from both PFC and NAc. Since the correlations to average
drinking values generated larger gene lists, we focused our analysis
on these data and the genes showing overlap with the PC analysis.
Nucleus Accumbens. The 889 transcripts from NAc
correlating with average drinking values were analyzed by EASE
[26] for overrepresentation of functional categories compared with
all genes on the Mouse 430Av2 chip (Table S4). Major significant
groups include genes associated with synaptic vesicles, protein
transport, protein ubiquitination, chromatin modifications and
histone deacetylase complex as well as categories related to small
GTPase signal transduction, cytoskeletal organization and kinase
activity. A majority of the categories were also identified by
analysis with Bibliosphere and are bolded in Table S4. The top
canonical pathways identified by Ingenuity Pathway Analysis (see
below) also mirrored the Gene Ontology results. Phosphoinositol
3 kinase/Akt signaling, ephrin receptor signaling, PDGF signaling,
protein ubiquitination, and inositol metabolism were among the
significant canonical pathways.
Biological functions of our gene lists werefurther investigated using
the curated knowledge base in Ingenuity Pathway Analysis. This tool
generates networks of genes with known interactions or biological
function. One of the top networks generated through this process is
shown in Figure 2. This network included multiple genes related to
chromatin modification and regulation of transcription through
possible epigenetic mechanisms. Seven of the genes in this network
were also identified in the Gene Ontology Biological Process category
for establishment and/or maintenance of chromatin architectureand
are identified with arrows. Additionally, 5 probesets were identified in
the Gene Ontology cellular component for the histone deacetylase
complex: Hdac11 (NM_144919.2), Rbbp4 (NM_009030.3), Rbbp7
(NM_009031.3), Sap18 (NM_009119.3) and Suds3 (NM_178622.4).
All genes in this network were significantly correlated to average
ethanol drinking (Table 2). Rbbp4 and Rbbp7, retinoblastoma-binding
proteins, together with HDAC 1 and HDAC2, form the HDAC core
which is part of both the NuRD and Sin3a complexes involved in
transcriptional repression [29]. We previously showed that acute
ethanol treatment increases mRNA levels of Rbbp4 [20]. Hdac11,
histone deacetylase complex 11, functions to repress RNA expression
by removing acetyl groups from the core histones allowing DNA
packaging into dense chromatin structures [30]. Other genes in the
network (Mbd2, Mll1, Men1, Ehmt2,a n dDnmt1) are involved in DNA
methylation events and work concurrently to repress transcription
[31,32].
The relative expression of select genes in this network in the top
quartile of high ethanol drinkers (.7 g/kg/18 h) and the bottom
quartile of low ethanol drinkers (,2 g/kg/18 h) are summarized
in Figure 2B. Myst3 (NM_001081149), Hdac11 and Ehmt2
(NM_147151) were significantly different in high versus low
drinkers by t-test at p,0.05. Myst3, Myst histone acetyl transferase
3, is a member of a mouse histone acetyl transferase (HAT)
complex that increases DNA transcription [33] by acetylating
histone tails. Acetylation of histone tails opens up the chromatin
structure to allow transcription factors and associated proteins
access to the DNA and increase gene transcription. Many genes
were in HDAC complexes (Rbbp4, Rbbp7), had intrinsic HDAC
activity (Hdac11) or were involved in methylation of DNA (Men1
(NM_001168488), Mbd2 (NM_010773.2), Mll1 (NM_001081049),
Ehmt2). These genes are believed to cause transcriptional silencing
by removing acetyl groups from chromatin or increasing DNA
methylation.
Further network analysis identified genes involved in synaptic
vesicle formation and recycling (see Table 3). Genes involved in
dynamin-dependent vesicle recycling (Ap2a1 (NM_025606), Ap2a2
(NM_007459), Ap2m1 (NM_207255), Dnm1 (NM_144516), Dnm1l
(NM_028661), Vamp3 (NM_009498), and Vamp4 (NM_016796.3))
and synaptic vesicle biogenesis (Sh3gl2 (NM_019535), Sh3glb1
(NM_175141)) were generally positively correlated to ethanol
intake. This suggests that synaptic vesicle recycling may be
increased in mice prone to drinking greater amounts of ethanol.
Conversely, low drinking mice had higher Bdnf (NM_001037955)
expression. Bdnf may play a role to increase synaptogenesis in these
studies as it has been implicated in plasticity from multiple drugs of
abuse [34,35]. Moreover, BDNF has been demonstrated to
increase expression of genes correlated with synaptic vesicle
release, suggesting a possible causal relationship with the synaptic
vesicle-related genes mentioned above.
The gene lists generated from PC analysis were similar in
biological function. Overrepresented Gene Ontology categories
included the synaptic vesicle, chromatin modification, histone
methylation, Na
+K
+ ATPase activity and protein kinase activity
(Table S5). Many of the genes highlighted in the chromatin
modification and synaptic vesicle formation and recycling
networks described above were present in the principal component
analysis (highlighted in bold in Table 2).
Prefrontal Cortex. Primary analyses of gene transcripts
differentially regulated by ethanol drinking in the prefrontal
cortex yielded 850 transcripts by RMA summarization, using a
false discovery rate of 1% (Table S2). The gene list was entered
into EASE and Bibliosphere analysis to identify over-represented
functional categories as compared to all the transcripts on the
Mouse430Av2 chips. The following categories were statistically
over-represented at p,0.05 in both analyses (see Table S4):
mitochondrial inner membrane, oxidoreductase activity, cell
projection and regulation of cell shape. The top canonical
pathways identified by Ingenuity Pathway Analysis mirrored
some results from EASE and Bibliosphere (mitochondrial
dysfunction and ubiquinone biosynthesis) and identified
involvement of other signaling pathways: IL2, Pten, Jak/Stat
and glucocorticoid receptor signaling.
Ingenuity network analysis identified potential involvement of
PFC glutamate receptor signaling (Figure 3) in the variation of
ethanol drinking behaviors. This network contained several
ionotropic glutamate receptor subunits, NMDA receptor subunits
2B and 3B (Grin2b (NM_008171), Grin3b (NM_028388)) and the
kainite receptor (Grik1 (NM_010348)), as well as genes that bind
(Htt (NM_010414)) or are regulated by glutamate receptors (Dlg4
(NM_001109752) aka Psd95). The NR2b subunit of the NMDA
receptor was positively correlated to ethanol drinking with the
lowest drinking mice having lower expression (Figure 3), while the
NR3b subunit and kainate receptor (Grik1) were correlated
negatively to ethanol drinking. Tyrosine hydroxylase, the rate-
limiting enzyme in catecholamine synthesis involved in the
conversion of tyrosine to dopamine, was also positively correlated
to ethanol drinking (Figure 3).
Functional overrepresentation analysis of the PFC gene list
derived from principal component derivation of the behavioral
data revealed biological categories related to mitochondria such as
electron transport, respiratory chain and mitochondrial dysfunc-
tion (Table S5) that overlapped with the averaged drinking data
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also present in the PC analysis. Stress activated protein kinase
signaling and retinoic acid signaling were over-represented in the
principal component analysis, but not in the average drinking
correlation analysis.
Ventral Midbrain Region. In the VMB, 559 transcripts
were significantly correlated to ethanol drinking intake, using a
false discovery rate of 1%. Gene Ontology analysis revealed only a
few significant categories (Table S3) that were surprisingly
cohesive (locomotor behavior, cell adhesion, cell projection and
Figure 2. Chromatin modification genes differentially regulated in the nucleus accumbens of ethanol drinking mice. A. Network of
genes involved in chromatin modification generated through the use of Ingenuity Pathways Analysis (www.ingenuity.com). Red arrows indicate
genes identified in Gene Ontology Biological Process for establishment and/or maintenance of chromatin architecture. Genes significantly correlated
to ethanol drinking are colored pink to red based on significance. Solid arrowheads reflect ‘‘acts on’’ interactions while lines without arrow indicate
binding interactions only. Solid and dotted lines indicate, respectively, direct vs. indirect interactions. B. RMA expression of transcripts in networks
involved in chromatin architecture. Low and high refer to the lowest vs. highest quartiles of ethanol drinkers. * p,0.05 by t-test.
doi:10.1371/journal.pone.0021100.g002
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chemotaxis may be affected in the VMB. Corresponding analysis
using Bibliosphere and the canonical pathways in Ingenuity
identified many of the same categories (Table S3). Gene networks
identified by Ingenuity Pathway Analysis did not reveal additional
conserved biological functions for the ventral midbrain region.
Despite having a slightly lower percentage of genes overlapping
with data from the average drinking analysis, the VMB gene list
correlating to principal component analysis of the behavioral data
had similar functional categories identified by Gene Ontology
analysis (glycosaminoglycan degradation, locomotor behavior, and
toll-like receptor signal; see Table S4).
Characterization of select genes
We used Western blot analysis to further confirm the
microarray results of select genes. RAB3A (NM_009001) was
chosen for its documented role in synaptic vesicle trafficking. In a
separate cohort of mice (Exp. 2), RAB3A expression was
determined in high (n=5, ethanol intake .7-g/kg) and low
(n=5, ethanol intake ,2-g/kg) drinking mice (Figure 4). RAB3A
expression was significantly lower in mice consuming less than 2-
g/kg ethanol than in mice consuming more than 7-g/kg ethanol
(p,0.05, T-test). Western blot analysis showed a 1.7 fold greater
level of RAB3A expression in high drinking mice, similar to what
was seen with mRNA expression changes in the microarray
Table 2. Genes involved in chromatin remodeling identified in nucleus accumbens.
Gene
Symbol Gene Name Probeset ID R value p value Function Transcription
Mbd2 methyl-CpG binding domain protein 2 1425803_a_at 20.515 1.00E-03 binds methylated DNA silences
Men1 multiple endocrine neoplasia 1 1416348_at 20.480 2.84E-03 methylated Lys4 Histone H3 silences
Ehmt2 euchromatic histone lysine N-
methyltransferase 2
1426888_at 20.482 2.69E-03 methylates Lys9 Histone H3 silences
Rbbp7 retinoblastoma binding protein 7 1415775_at 20.481 2.75E-03 subunit of core HDAC complex silences
Rbbp4 retinoblastoma binding protein 4 1434892_x_at 0.505 1.39E-03 member of NuRD and Sin3A
complex
silences
Myst3 MYST histone acetyltransferase 3 1436315_at 0.650 7.92E-06 acetylated histones activates
Hdac11 histone deacetylase 11 1451229_at 0.522 8.34E-04 deacetylates histones silences
Cbx5 chromobox homolog 5 (Drosophila HP1a) 1454636_at 0.512 1.10E-03 binds acetylated histone 3 silences
Gene names in bold were also identified by the principal component analysis.
doi:10.1371/journal.pone.0021100.t002
Table 3. Genes from nucleus accumbens involved in synaptic vesicle formation and recycling.
Gene Name Gene Symbol Probeset ID R value q value
adaptor protein complex AP-2, alpha 1 subunit Ap2a1 1460724_at 0.484 2.55E-03
adaptor protein complex AP-2, alpha 2 subunit Ap2a2 1452490_a_at 20.485 2.45E-03
adaptor protein complex AP-2, mu1 Ap2m1 1450894_a_at 0.634 1.35E-05
brain derived neurotrophic factor Bdnf 1422168_a_at 20.470 3.62E-03
dynamin 1 Dnm1 1460365_a_at 0.541 4.38E-04
dynamin 1-like Dnm1l 1428087_at 20.447 6.21E-03
protein kinase, AMP-activated, beta 1 non-catalytic subunit Prkab1 1452457_a_at 20.455 5.27E-03
Rab acceptor 1 (prenylated) Rabac1 1427773_a_at 20.525 7.57E-04
RAB3A, member RAS oncogene family Rab3a 1422589_at 0.588 8.14E-05
secretory carrier membrane protein 1 Scamp1 1426775_s_at 0.450 5.80E-03
SH3-domain GRB2-like 2 Sh3gl2 1418792_at 20.451 5.74E-03
SH3-domain GRB2-like B1 (endophilin) Sh3glb1 1418011_a_at 0.612 3.23E-05
solute carrier family 1 (neuronal/epithelial high affinity glutamate
transporter), member 1
Slc1a1 1448299_at 0.461 4.48E-03
solute carrier family 2 (facilitated glucose transporter), member 1 Slc2a1 1426600_at 0.458 4.82E-03
synaptophysin Syp 1448280_at 0.573 1.48E-04
synaptotagmin II Syt2 1420418_at 20.515 9.91E-04
syntaxin 6 Stx6 1431646_a_at 20.507 1.29E-03
vesicle-associated membrane protein 3 Vamp3 1437708_x_at 0.552 3.06E-04
vesicle-associated membrane protein 4 Vamp4 1422896_at 0.459 4.76E-03
Genes in bold were also identified by principal component analysis.
doi:10.1371/journal.pone.0021100.t003
Genomics of Ethanol Drinking Individual Variation
PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e21100results. Additional protein studies were conducted for BDNF
(Bdnf; NM_007540)and dynamin (Dnm1; NM_010065). These
showed trends but did not reach statistical significance (p=0.3 and
p=0.2, respectively), as might be expected from the small
magnitude changes in mRNA abundance seen with microarrays.
Rather than study larger numbers of animals for protein
quantitation, we further validated our array results through
bioinformatics and behavioral pharmacology studies as outlined
below.
Associations with genetic ethanol drinking phenotypes
Extensive prior microarray studies have been done comparing
basal brain gene expression across multiple mouse strains with
divergent ethanol drinking phenotypes. A large meta-analysis of
this data identified gene expression correlated with ethanol
drinking behavior across these multiple genetic models [27]. We
predicted that a subset of genes having correlation with individual
drinking behavior within a single inbred strain would overlap with
the genetically derived gene sets associated with drinking behavior.
Out of 889 significantly regulated transcripts in the NAc, 202
transcripts (p,10
234, Chi-square analysis) were also identified in
the meta-analysis (see Figure S2b). Functional categories of these
genes remained similar to our original analysis. PI3K/Akt
signaling, protein ubiquitination and genes involved in synaptic
vesicles were still highly represented. One of these genes, syntaxin-
binding protein 1 (Stxbp1 (NM_009295)) has been previously
identified as a putative candidate for an ethanol-drinking locus on
Chromosome 2 [12]. In the PFC, 168 genes out of 850 (p,10
218,
Chi-square) were also identified by the meta-analysis (see Figure
S2c). Mitochondrial dysfunction and PTEN signaling remained
top biological functions. However, genes involved in glutamate
receptor signaling were not represented on this list since this
category was not enriched in the meta-analysis. Genes involved in
retinoic acid signaling were over-represented in our principal
component analysis and were also in the meta-analysis dataset.
Retinoic acid signaling plays a role in the differentiation and
function of dopaminergic pathways [36]. In the VMB, 108 genes
out of 435 (p,10
24, Chi-square) were in common with the meta-
analysis results (Figure S2d). Glycosaminoglycan degradation and
cell movement were again identified as top biological functions.
The highly significant overlap between our gene list and those of
the meta-analysis across mouse lines genetically selected for
differences in ethanol intake as well as the degree of overlap
between functional gene categories in these two independent
studies, both serve to validate our microarray data in terms of
relevance to ethanol consumption.
Figure 3. Network of genes involved in glutamate signaling in the prefrontal cortex of ethanol drinking mice. Network of genes
involved in glutamate signaling generated through the use of Ingenuity Pathways Analysis (www.ingenuity.com). Genes significantly correlated to
ethanol drinking are colored pink to red based on significance.
doi:10.1371/journal.pone.0021100.g003
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The bioinformatics analysis of NAc genes correlating with
ethanol intake showed an over-representation for genes involved in
chromatin remodeling, particularly histone acetylation. Such
epigenetic modifications have been shown to play a role in
responses to other drugs of abuse [37,38]. To perform a functional
validation of our microarray data regarding the role of chromatin
modification genes in ethanol drinking, Trichostatin A (TSA), an
inhibitor of class I (HDAC isoforms 1, 2, 3, 8 and 11) and class II
HDACs (isoforms 4, 5, 6, 7, 9 and 10) [39,40], was examined to
determine effects on ethanol drinking. Similar doses of TSA have
been shown to increase histone acetylation in the brain, rescue
memory consolidation and increase cFos and cJun mRNA
expression [41,42]. We hypothesized that if chromatin acetylation
events were indeed involved in the drinking phenotype, admin-
istration of an HDAC inhibitor would alter ethanol intake/
preference and potentially reduce individual variation in drinking
behavior. Following baseline ethanol drinking for seven days, TSA
(2 mg/kg, i.p.) was administered for five consecutive days. Ethanol
was freely available 24 hours/day during and for 4 weeks
following TSA administration. Both TSA and vehicle-treated
groups showed decreased ethanol intake on treatment days, likely
due to the acute stress of injections (not shown). Following the
treatment period, TSA-treated animals showed significantly
increased ethanol drinking over baseline intake at three and four
weeks following administration (1-way repeated measures AN-
OVA with Sheffe post-hoc, p,0.01) while vehicle treated animals
showed no significant change (Figure 5A). Vehicle treated animals
showed a gradual return to baseline drinking over the four weeks
following injections. Two-way repeated measures ANOVA using
weekly ethanol intake after treatment as the dependent variable
revealed a main effect of time (F(3, 72)=9.03, p,0.0001).
Treatment and treatment x time interactions did not show
significant effects likely due to gradual onset of the TSA response
and the slight time-dependent changes in the vehicle-treated
animals. However, post-hoc analyses indicated that vehicle and
TSA-treated group ethanol intakes were significantly different
from one another at week 3 and week 4 (Sheffe, p,0.02). There
was no effect of TSA treatment on total fluid consumed over the
course of the experiment (data not shown) and, in a separate
experiment, TSA treatment had no effect on the kinetics of
ethanol metabolism following an i.p. injection of 2-g/kg ethanol
(Figure 5B). Western blot analysis for histone H4 hyperacetylation
confirmed elevated H4 acetylation levels 24 hours after a single 2-
mg/kg TSA i.p. injection (Figure S3).
We hypothesized that TSA treatment might also reduce the
variability of ethanol intake in individual mice as well as alter
overall ethanol intake. However, the relatively small sample size
for this experiment (n=9 for each treatment group) did not allow a
definitive conclusion as to whether TSA affected the overall
distribution of drinking values, since most animals showed
increased drinking following TSA (not shown).
Discussion
Our studies here showed that C57BL/6NCrl mice express a
striking degree of stable, inter-individual variation in ethanol
drinking behavior with greater than 10-fold differences within a
drinking session. We suspect these differences were generated by
Figure 4. RAB3A expression in high and low drinking mice. A.
Western blot of nucleus accumbens total protein probed with RAB3A
and beta-actin. B. Quantitation of western blot analysis, area under the
curve (AUC) RAB3A expression normalized to total beta-actin. LOW
,2 g/kg EtOH, HIGH .7 g/kg EtOH. * p,0.05, by t-test.
doi:10.1371/journal.pone.0021100.g004
Figure 5. Histone deacetylase activity inhibition increases
ethanol intake. A. Average weekly ethanol intake of C57BL/6NCrl
mice after i.p. treatment with 2 mg/kg trichostatin A (TSA) or vehicle
(n=9) for 5 days. Both groups had identical baseline average ethanol
intake (dotted line) prior to treatment with TSA. TSA caused ethanol
intake to increase significantly by weeks 3–4 post-treatment (*p,0.001
vs. baseline; #p,0.02 vs. vehicle at same time points). B. Blood ethanol
concentration in TSA and vehicle treated mice following a 2-mg/kg
ethanol injection (i.p.).
doi:10.1371/journal.pone.0021100.g005
Genomics of Ethanol Drinking Individual Variation
PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e21100subtle environmental differences such as rearing behaviors [43,44],
intrauterine position, social interactions or stress [45,46]. Individ-
ual variation within the C57 substrains has been reported for
ethanol drinking behaviors [16,17,47] as well as in stress
responsiveness [48] that may be a contributing factor to ethanol
preference [49,50,51]. For example, C57BL/6J mice are known to
consume slightly more ethanol in a 2 bottle choice paradigm than
C57BL/6NCrl [19,52] and also display variation of individual
ethanol intake (unpublished observation), albeit the range is
smaller than with C57BL/6NCrl mice. C57BL/6J mice have
several chromosomal regions that are duplicated in comparison to
C57BL/6NCrl mice [52], and may account for the differences in
overall consumption and range of individual variation between the
two strains. In the C57BL/10 substrain, Little et al. reported that
within-strain preference variation was not correlated with gender
or ethanol metabolism, and could not be altered by simple
environmental disturbances [18]. Gonzalez et al. have shown that
C57BL6/J and C57BL/6NCrl also do not differ in ethanol
metabolism rates [53]. Regardless of which environmental
conditions may have contributed to variation in ethanol drinking
behaviors, we hypothesized that the differences could be mediated
by individual variation in basal gene expression.
The studies here employed a unique experimental design that
allowed long-term measures of ethanol drinking behavior, ensured
that such behavior was stable upon reinstatement, and permitted
assaying gene expression differences in individual animals off
ethanol. This allowed identification of expression patterns
presumably ‘‘predictive’’ of drinking behavior rather than simply
resulting from such. However, even with the current design, we
cannot totally eliminate the possibility that some of our gene
expression results reflect, rather than cause, individual variation in
drinking behavior. Additionally, even though the behavioral data
showed extinction of an ethanol deprivation effect after several
cycles of withdrawal and reinstatement (Figure S1), we cannot
exclude that some of our microarray results do indeed reflect
expression changes secondary to ethanol deprivation. Perhaps
most likely, there could be a complex interaction between basal,
ethanol-deprivation and ethanol-responsive gene expression pat-
terns underlying these microarray results and perpetuating the
long-term drinking patterns seen in these animals. However, as
discussed below, the highly significant overlap of our expression
gene sets with data from a meta-analysis on basal gene expression
correlating with ethanol consumption [27], strongly suggests that
our results largely represent basal individual variation in gene
expression that influenced drinking behavior.
The current studies showed a potential role for epigenetic
regulation of ethanol preference in B6 mice. In the NAc, genes
with chromatin remodeling Gene Ontology function or classified
in the HDAC complex had differential expression between high
and low ethanol-drinking animals (see Table 2). Intriguingly, genes
involved in both histone modifications as well as genes involved in
DNA methylation events were significantly altered in the nucleus
accumbens but not in other brain regions assayed. Thus, our
genomic findings suggest an extensive and complex representation
of chromatin modification gene networks as contributing to
variation in ethanol intake specifically in the nucleus accumbens.
Inhibiting HDAC activity with TSA injections increased
ethanol intake above baseline and vehicle-treated levels, support-
ing a role for chromatin modifications in the modulation of
ethanol preference. The complex changes in chromatin modifica-
tion gene expression made it difficult to predict how directly
altering histone acetylation might affect drinking behavior. We
suggest, however, that any TSA-induced change in ethanol
drinking across individuals or as a population is supportive of
our hypothesis regarding a role of chromatin modification in
driving individual variation in ethanol intake. This data is the first
to show modulation of drinking behavior by altering chromatin
acetylation. However, evidence of ethanol-induced chromatin
remodeling has been reported in hepatocytes [54] and in mouse
brain [55]. In cultured cortical neurons, ethanol increases NR2B
transcription possibly through epigenetic modifications such as
methylation of CpG islands [56]. Acute ethanol increases histone
H3 and H4 acetylation and decreases HDAC activity in amygdala,
while ethanol withdrawal produces the opposite response with
decreased histone acetylation [57]. Social stress induces histone
H3 demethylation at certain Bdnf promoters, leading to decreased
Bdnf transcription [58]. Together, these studies demonstrate that
environmental factors such as social stress or drug taking can
modify chromatin and support a role for chromatin remodeling in
the formation of stable neuronal adaptations underlying individual
differences in drinking behavior.
Our bioinformatics analysis of gene expression correlating with
ethanol drinking also identified gene networks involved in synaptic
vesicle biogenesis and recycling (Table 3). Many of these genes
have previously been implicated as playing a role in ethanol
drinking or acute response to ethanol. For example, syntaxin-
binding protein, STXBP1, anchors synaptic vesicles to the plasma
membrane and was positively correlated to ethanol drinking in our
studies. Stxbp1 was previously identified as a candidate gene for a
mouse Chr2 ethanol preference locus [12]. RAB3A, a small
GTPase associated with synaptic vesicle trafficking and neuro-
transmitter release [59], was positively correlated to ethanol intake
and protein expression was 1.7 fold higher in heavy drinking mice.
This gene may play a role in sensitivity to the acute ataxic and
sedative effects of ethanol in C. elegans and mice [60].
We also identified an inverse correlation between Bdnf mRNA
levels and individual ethanol consumption. BDNF regulates
multiple synaptic vesicle-related proteins, including several listed
in Table 3, such as synaptotagmin, synaptophysin [61], AP2
complexes [62], and STXBP1 [63]. BDNF has been implicated in
neuroplasticity from multiple drugs of abuse [34,35]. In clinical
studies, peripheral BDNF is lower in dependent alcoholics and
patients with a positive family history of dependence as compared
to normal controls and dependent patients with a negative family
history [64]. McGough et al. [65] also showed that Bdnf under-
expression in Bdnf+/- mice caused increased ethanol consumption,
consistent with Bdnf mRNA expression observed in the current
study, where Bdnf is lowest in mice with the highest ethanol intake.
We do not believe, therefore, that Bdnf expression levels seen in
our studies were secondary to ethanol exposure itself. In support of
this, we and other investigators have shown that acute ethanol
injection (2 g/kg i.p.) in B6 or D2 mice increases Bdnf expression
and that after 4 weeks of 2-bottle choice ethanol drinking, Bdnf is
increased in the dorsal striatum versus non-ethanol controls
[20,65]. Thus, we suggest that lower Bdnf expression in the low
drinking mice was possibly a causal factor in individual drinking
behavior variance, rather than secondary to drinking behavior
itself. We cannot currently exclude the possibility that ethanol
drinking followed by withdrawal (4 days) caused the correlated
changes in Bdnf expression. Together, these findings on Bdnf and
synaptic vesicle-related gene expression are strong evidence
supporting an important link between regulation of synaptic
vesicles and individual variation in ethanol intake.
In the present study, many of the most robust gene expression
changes were found in the nucleus accumbens and prefrontal
cortex. Brain regional differential gene expression is not surprising
considering the proposed different roles of each region in ethanol
responses [66]. Furthermore, we have seen such inter-region
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expression only being regulated in nucleus accumbens [20]. The
regional differences are potentially functionally significant. For
example, glutamate signaling, the major excitatory feedback to the
ventral tegmental area, was altered in prefrontal cortex. The
finding of expression differences related to potential epigenetic
regulation events only in nucleus accumbens, is particularly
intriguing given the known role of that region in drug reward.
Importantly, we found significant overlap between our gene lists
and a previously published meta-analysis of basal brain gene
expression across mouse strains with differing ethanol preference
[27]. Several functional categories potentially involved in drinking
phenotypes were also over-represented in both studies, including
PI3K/Akt and PTEN signaling, protein ubiquitination and
mitochondrial dysfunction. These functional categories together
suggest a role for cell survival pathways, altered energy metabolism
or potential neuronal toxicity due to ethanol consumption.
However, animals from the meta-analysis never consumed
ethanol. Therefore it is possible that animals with a proclivity to
drink ethanol may have altered signaling in these pathways prior
to drinking.
In conclusion, the current experiments have described persistent
inter-individual variation of ethanol drinking behaviors in B6 mice
and, more importantly, they define gene expression networks that
may underlie these individual differences. This study utilizes
variation within an inbred strain to minimize genetic influences,
isolating changes in gene expression due specifically to environ-
mental factors. These experiments have identified several gene
networks previously implicated in responses to ethanol in the NAc
and PFC: glutamate signaling, BDNF and genes involved in
synaptic vesicle function. Perhaps most importantly, our expres-
sion studies and behavioral analysis following histone deacetylase
inhibition implicate epigenetic factors involving chromatin acet-
ylation and/or methylation as contributing to environmental
modulation of ethanol intake. Defining specific gene networks
targeted by these epigenetic modifications is an important goal of
ongoing studies. The novel findings presented here could
contribute to understanding mechanisms involved in individual
risk for alcohol abuse and alcoholism in humans. Future work will
focus on characterizing the genesis and implications of gene
network alterations and epigenetic modifications associated with
variation in ethanol drinking.
Supporting Information
Figure S1 Average Ethanol Intake Over 16 Days Of
Access. Ethanol intake was significantly increased following
repeated ethanol deprivations (**p,0.001 day 4 vs. day 9,
*p,0.01 day 4 vs. day 17, Bonferroni Multiple Comparison test).
Ethanol consumption did not differ from baseline after the third
deprivation (p.0.05, day 4 vs. day 25).
(TIF)
Figure S2 Genes Differentially Regulated In Ethanol
Drinking Mice. A. Venn diagram overlapping and non-
overlapping genes in each brain region significantly correlated to
drinking at FDR,0.01. Region-specific expression patterns are
represented as shaded circles (nucleus accumbens (NAc), dark;
prefrontal cortex (PFC), open; ventral midbrain (VMB), light). B–
D. Hierarchical clustering of transcripts significantly correlated to
ethanol drinking in the NAc (B), PFC (C) and VMB (D). Genes
that overlap with the meta-analysis are labeled in blue. Genes that
overlap with the principal component analysis are labeled in
orange. Red color indicates higher relative expression and green
indicates lower expression. Columns are arranged according to
drinking behavior averaged over the last 8 days of intake, with low
drinking mice on the left, progressing to higher drinking mice on
the right.
(TIF)
Figure S3 Western Blot Analysis Of TSA Effects On
Histone H4 Acetylation. Western blotting for acetyl-Histone-
H4 was used to verify CNS activity of i.p. TSA. C57BL/6NCrl
mice (n=12) received a single i.p. injection of 2 mg/kg TSA or
vehicle. After 24 hours, nucleus accumbens was dissected for
Western blotting for acetyl-histone H4 (upper panel) or GAPDH
as a loading control (lower panel). Results verify increased H4
acetylation in NAc after TSA treatment.
(TIF)
Table S1 Average Ethanol Intake and Preference for six
C57BL/6NCrl litters. Average ethanol intake and preference for
six separate litters of male mice (n=425/litter) was calculated
over 14 days of 24 h access to 2-bottle choice ethanol. There was
no significant difference in intake or preference as reported in
Results.
(XLSX)
Table S2 Results from Correlation with Average Drinking. Data
are gene lists and statistics for gene expression correlating with
individual average ethanol intake from the last 8 days of ethanol
access following a third round of ethanol deprivation. Data are
presented for each brain region separately.
(XLSX)
Table S3 Gene Lists from Principal Component Analysis. Data
are gene lists and statistics for gene expression correlating with
ethanol intake data subjected to principal component analysis as in
Methods following a third round of ethanol deprivation. Data are
presented for each brain region separately. Categories in bold
were also significant in the averaged drinking analysis (Table S2).
(XLSX)
Table S4 Over-Represented Gene Categories From Gene
Expression Significantly Correlated To Average Ethanol Drinking.
Gene data from Table S2 was analyzed by functional over-
representation analysis versus Gene Ontology categories. Catego-
ries in bold were also significant in the Bibliosphere analysis.
(XLSX)
Table S5 Gene Categories Significantly Over-Represented
From Principal Component Analysis In Ethanol Drinking
C57BL/6NCrl Mice. Gene set data from Table S3 was analyzed
by functional over-representation analysis versus Gene Ontology
categories. Gene categories in bold were also significantly over-
represented in the correlation analysis (Table S4).
(XLSX)
Acknowledgments
The authors would like to thank Paul Vorster for technical assistance and
Milton Omar Faison, PhD, for critical reading and preparation of the
manuscript.
Author Contributions
Conceived and designed the experiments: JTW MFM. Performed the
experiments: JTW JAW KLS. Analyzed the data: JTW JAW MIC KJA
KLS MFM . Wrote the paper: JTW JAW MFM. Edited the manuscript:
JTW JAW MIC KJA KLS MFM.
Genomics of Ethanol Drinking Individual Variation
PLoS ONE | www.plosone.org 11 June 2011 | Volume 6 | Issue 6 | e21100References
1. Administration SAaMHS (2005) Results from the 2004 National Survey on
Drug Use and Health: National Findings Rockville, MD. Office of Applied
Studies.
2. Chin JH, Goldstein DB (1977) Drug tolerance in biomembranes: A spin label
study of the effects of ethanol. Science 196: 684–685.
3. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death
in the United States, 2000. Jama 291: 1238–1245.
4. Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science
236: 410–416.
5. Enoch MA, Goldman D (2001) The genetics of alcoholism and alcohol abuse.
Curr Psychiatry Rep 3: 144–151.
6. Gordis E, Tabakoff B, Goldman D, Berg K (1990) Finding the gene(s) for
alcoholism. Jama 263: 2094–2095.
7. Radel M, Goldman D (2001) Pharmacogenetics of alcohol response and
alcoholism: the interplay of genes and environmental factors in thresholds for
alcoholism. Drug Metab Dispos 29: 489–494.
8. Crabbe JC (2002) Genetic contributions to addiction. Annu Rev Psychol 53:
435–462.
9. Lovinger DM, Crabbe JC (2005) Laboratory models of alcoholism: treatment
target identification and insight into mechanisms. Nat Neurosci 8: 1471–1480.
10. Phillips TJ, Crabbe JC, Metten P, Belknap JK (1994) Localization of genes
affecting alcohol drinking in mice. Alcohol Clin Exp Res 18: 931–941.
11. Shirley RL, Walter NA, Reilly MT, Fehr C, Buck KJ (2004) Mpdz is a
quantitative trait gene for drug withdrawal seizures. Nat Neurosci 7: 699–700.
12. Fehr C, Shirley RL, Crabbe JC, Belknap JK, Buck KJ, et al. (2005) The syntaxin
binding protein 1 gene (Stxbp1) is a candidate for an ethanol preference drinking
locus on mouse chromosome 2. Alcohol Clin Exp Res 29: 708–720.
13. Bachmanov AA, Reed DR, Tordoff MG, Price RA, Beauchamp GK (1996)
Intake of ethanol, sodium chloride, sucrose, citric acid, and quinine
hydrochloride solutions by mice: a genetic analysis. Behav Genet 26: 563–573.
14. Belknap JK, Crabbe JC, Young ER (1993) Voluntary consumption of ethanol in
15 inbred mouse strains. Psychopharmacology (Berl) 112: 503–510.
15. McClearn GE (1972) Genetics as a tool in alcohol research. Ann N Y Acad Sci
197: 26–31.
16. Dole VP, Ho A, Gentry RT, Chin A (1988) Toward an analogue of alcoholism
in mice: analysis of nongenetic variance in consumption of alcohol. Proc Natl
Acad Sci U S A 85: 827–830.
17. Little HJ, O’Callaghan MJ, Butterworth AR, Wilson J, Cole J, et al. (1999) Low
alcohol preference among the "high alcohol preference" C57 strain of mice;
preference increased by saline injections. Psychopharmacology (Berl) 147:
182–189.
18. O’Callaghan MJ, Croft AP, Watson WP, Brooks SP, Little HJ (2002) Low
alcohol preference among the "high alcohol preference" C57/BL10 mice;
factors affecting such preference. Pharmacol Biochem Behav 72: 475–481.
19. Khisti RT, Wolstenholme J, Shelton KL, Miles MF (2006) Characterization of
the ethanol-deprivation effect in substrains of C57BL/6 mice. Alcohol 40:
119–126.
20. Kerns RT, Ravindranathan A, Hassan S, Cage MP, York T, et al. (2005)
Ethanol-responsive brain region expression networks: implications for behavioral
responses to acute ethanol in DBA/2J versus C57BL/6J mice. J Neurosci 25:
2255–2266.
21. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries
of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
22. Pavlidis P, Noble WS (2001) Analysis of strain and regional variation in gene
expression in mouse brain. Genome Biol 2: RESEARCH0042.
23. Saeed AI SV, White J, Li J, Liang W, Bhagabati N, et al. (2003) TM4: a free,
open-source system for microarray data management and analysis.
J Biotechniques 34: 374–378.
24. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies.
Proc Natl Acad Sci U S A 100: 9440–9445.
25. Team RDC (2009) R: A Language and Environment for Statistical Computing.
26. Hosack DA, Dennis G Jr., Sherman BT, Lane HC, Lempicki RA (2003)
Identifying biological themes within lists of genes with EASE. Genome Biol 4:
R70.
27. Mulligan MK, Ponomarev I, Hitzemann RJ, Belknap JK, Tabakoff B, et al.
(2006) Toward understanding the genetics of alcohol drinking through
transcriptome meta-analysis. Proc Natl Acad Sci U S A 103: 6368–6373.
28. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of
reward pathways. Trends Pharmacol Sci 13: 177–184.
29. Zoltewicz JS, Stewart NJ, Leung R, Peterson AS (2004) Atrophin 2 recruits
histone deacetylase and is required for the function of multiple signaling centers
during mouse embryogenesis. Development 131: 3–14.
30. Gregoretti IV, Lee YM, Goodson HV (2004) Molecular evolution of the histone
deacetylase family: functional implications of phylogenetic analysis. J Mol Biol
338: 17–31.
31. Smallwood A, Esteve PO, Pradhan S, Carey M (2007) Functional cooperation
between HP1 and DNMT1 mediates gene silencing. Genes Dev 21: 1169–1178.
32. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, et al. (2005)
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase
inhibitors. Proc Natl Acad Sci U S A 102: 749–754.
33. Kitabayashi I, Aikawa Y, Nguyen LA, Yokoyama A, Ohki M (2001) Activation
of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP
fusion protein. Embo J 20: 7184–7196.
34. Thomas MJ, Kalivas PW, Shaham Y (2008) Neuroplasticity in the mesolimbic
dopamine system and cocaine addiction. Br J Pharmacol 154: 327–342.
35. Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors
and structural plasticity in addiction. Neuropharmacology 56(Suppl 1): 73–82.
36. Samad TA, Krezel W, Chambon P, Borrelli E (1997) Regulation of
dopaminergic pathways by retinoids: activation of the D2 receptor promoter
by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl
Acad Sci U S A 94: 14349–14354.
37. Brami-Cherrier K, Valjent E, Herve D, Darragh J, Corvol JC, et al. (2005)
Parsing molecular and behavioral effects of cocaine in mitogen- and stress-
activated protein kinase-1-deficient mice. J Neurosci 25: 11444–11454.
38. Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, et al. (2004) Dopamine
D2-like antagonists induce chromatin remodeling in striatal neurons through
cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 90:
1117–1131.
39. Dokmanovic M, Marks PA (2005) Prospects: histone deacetylase inhibitors. J Cell
Biochem 96: 293–304.
40. Villar-Garea A, Esteller M (2004) Histone deacetylase inhibitors: understanding
a new wave of anticancer agents. Int J Cancer 112: 171–178.
41. Korzus E, Rosenfeld MG, Mayford M (2004) CBP histone acetyltransferase
activity is a critical component of memory consolidation. Neuron 42: 961–972.
42. Sng JC, Taniura H, Yoneda Y (2005) Inhibition of histone deacetylation by
trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after
kainate stimulation. Neurosci Lett 386: 150–155.
43. Brake WG, Zhang TY, Diorio J, Meaney MJ, Gratton A (2004) Influence of
early postnatal rearing conditions on mesocorticolimbic dopamine and
behavioural responses to psychostimulants and stressors in adult rats.
Eur J Neurosci 19: 1863–1874.
44. Meaney MJ, Brake W, Gratton A (2002) Environmental regulation of the
development of mesolimbic dopamine systems: a neurobiological mechanism for
vulnerability to drug abuse? Psychoneuroendocrinology 27: 127–138.
45. Holmes A, le Guisquet AM, Vogel E, Millstein RA, Leman S, et al. (2005) Early
life genetic, epigenetic and environmental factors shaping emotionality in
rodents. Neurosci Biobehav Rev 29: 1335–1346.
46. Lathe R (2004) The individuality of mice. Genes Brain Behav 3: 317–327.
47. Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC (2005) Evaluation of a
simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol
Behav 84: 53–63.
48. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, et al. (2007)
Molecular adaptations underlying susceptibility and resistance to social defeat in
brain reward regions. Cell 131: 391–404.
49. Rockman GE, Glavin GB (1984) Ethanol-stress interaction: differences among
ethanol-preferring rats’ responses to restraint. Alcohol 1: 293–295.
50. Rockman GE, Hall A, Hong J, Glavin GB (1987) Unpredictable cold-
immobilization stress effects on voluntary ethanol consumption in rats. Life
Sci 40: 1245–1251.
51. Volpicelli JR, Ulm RR, Hopson N (1990) The Bidirectional Effects of Shock on
Alcohol Preference in Rats. Alcoholism: Clinical and Experimental Research 14:
913–916.
52. Mulligan MK, Ponomarev I, Boehm SL 2nd, Owen JA, Levin PS, et al. (2008)
Alcohol trait and transcriptional genomic analysis of C57BL/6 substrains. Genes
Brain Behav 7: 677–689.
53. Ramachandra V, Phuc S, Franco AC, Gonzales RA (2007) Ethanol preference is
inversely correlated with ethanol-induced dopamine release in 2 substrains of
C57BL/6 mice. Alcohol Clin Exp Res 31: 1669–1676.
54. Shukla SD, Velazquez J, French SW, Lu SC, Ticku MK, et al. (2008) Emerging
Role of Epigenetics in the Actions of Alcohol. Alcohol Clin Exp Res.
55. Rulten SL, Ripley TL, Manerakis E, Stephens DN, Mayne LV (2006) Ethanol
modifies the effect of handling stress on gene expression: problems in the analysis
of two-way gene expression studies in mouse brain. Brain Res 1102: 39–43.
56. Marutha Ravindran CR, Ticku MK (2004) Changes in methylation pattern of
NMDA receptor NR2B gene in cortical neurons after chronic ethanol treatment
in mice. Brain Res Mol Brain Res 121: 19–27.
57. Pandey SC, Ugale R, Zhang H, Tang L, Prakash A (2008) Brain chromatin
remodeling: a novel mechanism of alcoholism. J Neurosci 28: 3729–3737.
58. Tsankova NM, Kumar A, Nestler EJ (2004) Histone modifications at gene
promoter regions in rat hippocampus after acute and chronic electroconvulsive
seizures. J Neurosci 24: 5603–5610.
59. Geppert M, Bolshakov VY, Siegelbaum SA, Takei K, De Camilli P, et al. (1994)
The role of Rab3A in neurotransmitter release. Nature 369: 493–497.
60. Kapfhamer D, Bettinger JC, Davies AG, Eastman CL, Smail EA, et al. (2008)
Loss of RAB-3/A in Caenorhabditis elegans and the mouse affects behavioral
response to ethanol. Genes Brain Behav 7: 669–676.
61. Yamada MK, Nakanishi K, Ohba S, Nakamura T, Ikegaya Y, et al. (2002)
Brain-derived neurotrophic factor promotes the maturation of GABAergic
mechanisms in cultured hippocampal neurons. J Neurosci 22: 7580–7585.
62. Beattie EC, Howe CL, Wilde A, Brodsky FM, Mobley WC (2000) NGF signals
through TrkA to increase clathrin at the plasma membrane and enhance
clathrin-mediated membrane trafficking. J Neurosci 20: 7325–7333.
Genomics of Ethanol Drinking Individual Variation
PLoS ONE | www.plosone.org 12 June 2011 | Volume 6 | Issue 6 | e2110063. Thakker-Varia S, Alder J, Crozier RA, Plummer MR, Black IB (2001) Rab3A is
required for brain-derived neurotrophic factor-induced synaptic plasticity:
transcriptional analysis at the population and single-cell levels. J Neurosci 21:
6782–6790.
64. Joe KH, Kim YK, Kim TS, Roh SW, Choi SW, et al. (2007) Decreased plasma
brain-derived neurotrophic factor levels in patients with alcohol dependence.
Alcohol Clin Exp Res 31: 1833–1838.
65. McGough NN, He DY, Logrip ML, Jeanblanc J, Phamluong K, et al. (2004)
RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that
regulates alcohol addiction. J Neurosci 24: 10542–10552.
66. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychophar-
macology 35: 217–238.
Genomics of Ethanol Drinking Individual Variation
PLoS ONE | www.plosone.org 13 June 2011 | Volume 6 | Issue 6 | e21100